Life cycle in practice: capacity building aiming European SME’s

The application of life cycle approaches – including life cycle assessment, ecodesign and environmental labelling – is becoming an increasing reality for business, and a growing challenge in many economic sectors. Businesses are facing increasing legal and market requirements to enhance resource efficiency and reduce the environmental impact of their products & services. To significantly address this challenge, the Life Cycle in Practice (LCiP) project was conceived, aiming to promote the uptake of LC approaches particularly in SMEs. The LCiP project helps SMEs in France, Belgium, Portugal and Spain reduce the environmental impacts of their products and services across the entire Life Cycle in three sectors: Buildings & Construction, Waste Management and Energy Equipment. LCiP’s specific objectives are to foster the widespread uptake of these approaches by SMEs beyond the duration of the project, by (i) Demonstrating the environmental and business benefits of applying LC Approaches through practical application in 32 businesses; (ii) Providing physical and online resource centres to support regional application of LC approaches; (iii) Building capacity for on-going implementation of LC approaches through a network of Life Cycle Champions and (iv) (Re)designing practical tools & methods tailored to the needs of the three industrial sectors. This paper presents the project's activities and expected results, as well as the conclusions of a maturity assessment on life cycle approaches that has been performed in the three sectors and four partner regions, as a means to identify needs and gaps that LCiP should fulfil

YY1 and MyoD are transcriptional activator and inhibitor, respectively, of the DUX4 gene that causes facioscapulohumeral muscular dystrophy (FSHD)

info:eu-repo/semantics/publishe

Demonstration of a monolithic multichannel module for multi-Gb/s intra-MCM optical interconnects

In this letter, we report on the demonstration of a 2.48-Gb/s multichannel, optical data-link for intramultichip module interconnects. The optical module was fabricated in Poly MethylMethAcrylate (PMMA) by deep proton lithography and monolithically integrates micromirrors and cylindrical lenses. With the same technology, we have also fabricated a single-channel optical bridge and used this component to demonstrate a proof-of-principle optical intrachip interconnect by establishing a digital data-link between optoelectronic transceivers integrated on the same chip.status: publishe

Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007

This study describes the results of in vitro antimalarial susceptibility assays and molecular polymorphisms of Plasmodium falciparum isolates from Cambodia. The samples were collected from patients enrolled in therapeutic efficacy studies (TES) conducted by the Cambodian National Malaria Control Program for the routine efficacy monitoring of artemisinin-based combination therapy (ACT) (artesunate-mefloquine and artemether-lumefantrine combinations). The isolates (n = 2,041) were obtained from nine sentinel sites during the years 2001 to 2007. Among these, 1,588 were examined for their in vitro susceptibilities to four antimalarials (artesunate, mefloquine, chloroquine, and quinine), and 851 isolates were genotyped for single nucleotide polymorphisms (SNPs). The geometric means of the 50% inhibitory concentrations (GMIC(50)s) of the four drugs tested were significantly higher for isolates from western Cambodia than for those from eastern Cambodia. GMIC(50)s for isolates from participants who failed artesunate-mefloquine therapy were significantly higher than those for patients who were cured (P, >0.001). In vitro correlation of artesunate with the other drugs was observed. The distributions of the SNPs differed between eastern and western Cambodia, suggesting different genetic backgrounds of the parasite populations in these two parts of the country. The GMIC(50)s of the four drugs tested increased significantly in eastern Cambodia during 2006 to 2007. These results are worrisome, because they may signal deterioration of the efficacy of artesunate-mefloquine beyond the Cambodian-Thai borde